NASDAQ:NDRA - Nasdaq - US29273B5003 - Common Stock - Currency: USD
3.98
+0.53 (+15.36%)
The current stock price of NDRA is 3.98 USD. In the past month the price decreased by -6.35%. In the past year, price decreased by -99.1%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 26.96 | 223.47B | ||
ISRG | INTUITIVE SURGICAL INC | 67.35 | 184.36B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.74 | 150.72B | ||
SYK | STRYKER CORP | 29.95 | 139.34B | ||
MDT | MEDTRONIC PLC | 15.76 | 107.94B | ||
BDX | BECTON DICKINSON AND CO | 14.74 | 58.89B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.25 | 44.70B | ||
IDXX | IDEXX LABORATORIES INC | 38.88 | 35.45B | ||
RMD | RESMED INC | 25.98 | 34.64B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.24 | 31.33B | ||
DXCM | DEXCOM INC | 43.43 | 28.10B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.84 | 23.53B |
ENDRA Life Sciences, Inc. develops medical imaging technology. The company is headquartered in Ann Arbor, Michigan and currently employs 21 full-time employees. The company went IPO on 2017-06-28. The firm's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. The company is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
ENDRA LIFE SCIENCES INC
3600 Green Ct Ste 350
Ann Arbor MICHIGAN 48105 US
CEO: Francois Michelon
Employees: 21
Company Website: https://www.endrainc.com/
Investor Relations: http://investors.endrainc.com/
Phone: 17343350468
The current stock price of NDRA is 3.98 USD. The price increased by 15.36% in the last trading session.
The exchange symbol of ENDRA LIFE SCIENCES INC is NDRA and it is listed on the Nasdaq exchange.
NDRA stock is listed on the Nasdaq exchange.
7 analysts have analysed NDRA and the average price target is 76.5 USD. This implies a price increase of 1822.11% is expected in the next year compared to the current price of 3.98. Check the ENDRA LIFE SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ENDRA LIFE SCIENCES INC (NDRA) has a market capitalization of 2.23M USD. This makes NDRA a Nano Cap stock.
ENDRA LIFE SCIENCES INC (NDRA) currently has 21 employees.
ENDRA LIFE SCIENCES INC (NDRA) has a support level at 3.51 and a resistance level at 3.99. Check the full technical report for a detailed analysis of NDRA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NDRA does not pay a dividend.
ENDRA LIFE SCIENCES INC (NDRA) will report earnings on 2025-05-12.
ENDRA LIFE SCIENCES INC (NDRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-90.5).
The outstanding short interest for ENDRA LIFE SCIENCES INC (NDRA) is 5.64% of its float. Check the ownership tab for more information on the NDRA short interest.
ChartMill assigns a fundamental rating of 2 / 10 to NDRA. No worries on liquidiy or solvency for NDRA as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months NDRA reported a non-GAAP Earnings per Share(EPS) of -90.5. The EPS increased by 60.31% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -258.47% | ||
ROE | -449.46% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to NDRA. The Buy consensus is the average rating of analysts ratings from 7 analysts.